China-headquartered global biopharmaceutical company Frontier Biotechnologies announced positive results from the Phase ...
Stopping children undergoing chemotherapy from feeling pain and other debilitating side-effects is the focus of research...
A surge in pharmaceutical R&D has led to an increase in the number of Cell & Gene Therapy (CGT) candidates being...
Bharat Serums and Vaccines (BSV), a leading biopharmaceutical company in India, has announced a meaningful collaboration...
Although Aduhelm, a monoclonal antibody targeting amyloid beta (Aβ), recently became the first US FDA app...
Griffith University has launched two cancer research centres backed by $4.6 million in funding from the Australian Cance...
A brain protein with high potential to delay or reverse the onset of Alzheimer’s disease has been exploited by New...
With multi drug-resistant tuberculosis (TB) causing outbreaks in both developing and developed nations, new treatments a...
Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed a new biomaterial made entirely...
A team of scientists led by Lee Kong Chian School of Medicine (LKCMedicine) at Nanyang Technological University, Singapo...
A pair of researchers at the University of Auckland in New Zealand has led a successful bid to trial regional hubs for d...
Scientists from A*STAR’s Institute of Molecular and Cell Biology (IMCB) and Genome Institute of Singapore (GIS), a...
Australian researchers may be a step closer to preventing Type 1 diabetes after identifying a crucial protein that could...
Scientists from the National University of Singapore (NUS) Department of Pharmacy have developed an improved pharmaceuti...
A joint research team from Li Ka Shing Faculty of Medicine, The University of Hong Kong (HKUMed) and City ...
Alzheimer’s disease, the most common form of dementia, currently has no cure or effective therapy, in part due to ...
MiRXES Pte Ltd, (HQ: Singapore) has launched the world’s first large-scale clinical research Project, CADENC...
Brii Biosciences, a multi-national company developing innovative therapies for diseases with significant unmet medi...
